Unconfigured Ad

Collapse

Sequencing by Oligo Ligation/Detection (Life Technologies)

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by ECO, 11-11-2007, 11:23 PM
63 responses
233,896 views
0 reactions
Last Post shahinda rezk  
Started by exprofiler, 09-22-2008, 08:10 AM
36 responses
56,627 views
0 reactions
Last Post ringo1230  
Started by GenomicIBK, 11-11-2011, 01:37 AM
3 responses
2,922 views
0 reactions
Last Post SeqAA
by SeqAA
 
Started by eoh001, 11-16-2011, 04:06 AM
0 responses
1,394 views
0 reactions
Last Post eoh001
by eoh001
 
Started by SamCurt, 11-04-2011, 07:45 PM
5 responses
4,545 views
0 reactions
Last Post epistatic  
Started by RPiddock, 09-26-2011, 05:50 AM
5 responses
2,525 views
0 reactions
Last Post sciencegnome  
Started by westerman, 07-08-2011, 12:47 PM
12 responses
4,711 views
0 reactions
Last Post Ori
by Ori
 
Started by cmm8cmm8, 03-20-2009, 08:24 AM
12 responses
8,646 views
0 reactions
Last Post alexbmp
by alexbmp
 
Started by JPC, 10-18-2011, 01:48 AM
5 responses
2,921 views
0 reactions
Last Post JPC
by JPC
 
Started by Jperrott, 10-20-2011, 04:10 PM
1 response
2,762 views
0 reactions
Last Post pmiguel
by pmiguel
 
Started by yasashiku, 10-20-2011, 07:47 AM
0 responses
1,249 views
0 reactions
Last Post yasashiku  
Started by chenglei, 09-22-2011, 06:54 PM
4 responses
2,741 views
0 reactions
Last Post AHarris
by AHarris
 
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 12:22 PM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Working...